相关实验视频

Updated: Jun 4, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

在非小细胞肺癌中,LRP1参与FHIT调节的HER2信号传递

Théophile Ponchel¹, Emma Loeffler¹, Julien Ancel²

¹Université de Reims Champagne-Ardenne, INSERM, P3Cell, UMR-S 1250, Reims, France.

European journal of cell biology

|January 3, 2025

概括

在非小细胞肺癌 (NSCLC) 中失去FHIT会增加HER2和LRP1,从而导致瘤的进展. 针对HER2和LRP1都可能改善FHIT阴性NSCLC的治疗方法.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
细胞信号传递细胞信号传递

背景情况:

在非小细胞肺癌 (NSCLC) 中,瘤抑制器脆弱胺三元组 (FHIT) 经常丢失.
FHIT损失与增加的HER2活性,上皮-介质细胞过渡 (EMT) 和对抗HER2药物的敏感性相关.
了解FHIT调节的HER2通路对于NSCLC治疗至关重要.

研究的目的:

为了阐明在NSCLC中FHIT调节的HER2信号通路.
确定FHIT介导的HER2信号传输和EMT中的新型参与者.
探索针对FHIT阴性NSCLC的潜在治疗策略.

主要方法:

转录组分析以确定潜在的信号参与者.
在80个NSCLC患者样本上进行免疫组织化学检查,以评估FHIT,HER2和LRP1的表达.
在肺细胞系中进行FHIT沉默实验.
功能性测试用于评估细胞增殖,入侵和EMT标记物.
使用抗HER2药物和LRP1沉默的向治疗实验.

主要成果:

低FHIT表达与NSCLC中的高HER2和LRP1表达有关.
在mRNA和蛋白质水平上,FHIT调节LRP1的表达.
LRP1 作用于 HER2 的下游; 抗 HER2 疗法逆转了 LRP1 的过度表达,但 LRP1 沉默不会影响 HER2 的活性.
由FHIT沉默引起的扩散和入侵依赖于LRP1.
在FHIT无活化后,LRP1调解了维门丁诱导.

结论:

在NSCLC中FHIT损失后,LRP1在HER2的下游功能促进EMT和瘤进展.
双重向HER2和LRP1为FHIT阴性NSCLC提供了一个潜在的治疗策略.
这项研究揭示了LRP1作为FHIT-HER2-EMT轴中的关键调解器.

关键词:

在EMT中,EMT是EMT.这就是FITIT.在HER2中,HER2是HER2.一个LRP1的LRP1 在NSCLCLC中,我们可以看到.

更多相关视频

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Receptor Tyrosine Kinases

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...